Drug Type Small molecule drug |
Synonyms 4-[4-(1-isopropyl-piperidin-4-yloxy)-benzyl]-morpholine |
Target |
Mechanism H3 receptor antagonists(Histamine H3 receptor antagonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC19H30N2O2 |
InChIKeyAYEMHSJPBSPTSA-UHFFFAOYSA-N |
CAS Registry397276-53-8 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Nervous System Diseases | Preclinical | US | 24 Mar 2005 |